Bayer | BAYN - Operating Expenses



Bayer reported EUR10.73B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Air Liquide EUR 4.22B 7.02B Jun/2025
Akzo Nobel EUR 2.32B 98M Jun/2025
Alcon AG USD 2.35B 344M Jun/2025
Amarin USD 58.77M 56.06M Mar/2025
Arkema EUR 2.23B 48M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
BASF EUR 14.94B 1.26B Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Corteva USD 4.62B 1.01B Jun/2025
Covestro EUR 3.33B 244M Jun/2025
Essilor EUR 12.02B 308M Jun/2025
Fresenius EUR 5.02B 57M Jun/2025
Fresenius Medical Care EUR 4.36B 189M Jun/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.96B 663M Jun/2025
GRIFOLS EUR 1.54B 24.64M Jun/2025
Henkel EUR 8.79B 620M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Johnson Matthey GBP 6.08B 1.02B Mar/2025
Linde USD 6.16B 144M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.22B 49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Nutrien USD 8.59B 3.72B Jun/2025
Philips EUR 3.85B 93M Jun/2025
PPG Industries USD 3.55B 342M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
SAP EUR 6.57B 109M Jun/2025
Solvay EUR 1.09B 4M Jun/2025
UCB EUR 2.36B 108M Dec/2024
Umicore EUR 8.39B 4.03B Jun/2025
Vinci EUR 31.4B 1.66B Jun/2025